Liver Diseases  >>  TMC647055  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TMC647055 / J&J
NCT01202825: TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

Completed
1
72
Europe
TMC647055, Placebo, TMC435
Tibotec Pharmaceuticals, Ireland
Hepatitis C
11/11
11/11
NCT01907724: Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)

Completed
1
34
US
IDX719, Simeprevir, Olysio™, TMC647055, RTV, Norvir™
Merck Sharp & Dohme LLC, Janssen Research & Development, LLC
Hepatitis C, Chronic
08/13
08/13
NCT01582035: Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

Completed
1
7
Europe
TMC647055, TVR, PegFN, RBV
Janssen R&D Ireland
Hepatitis C
11/13
11/13

Download Options